Anticoagulant Reversal Drugs Market Development, Trends, Segmentations Analysis

1
Anticoagulant Reversal Drugs Market Global
Analysis and Forecast to 2028

• Published Date Jan 2021

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Anticoagulant Reversal Drugs Market Forecast to
  2027 - COVID-19 Impact and Global Analysis By
  Product (Prothrombin Complex Concentrates,
  Vitamin K, Protamine, Tranexamic Acid,
  Idarucizumab, and AndeXXa), and Distribution
  channel (Hospital Pharmacies, Retail Pharmacies,
  and Others) and Geography.
• The anticoagulant reversal drugs market is
  expected to reach US 2,276.54 million by 2027
  from US 922.55 million in 2019 the market is
  estimated to grow at a CAGR of 12.6 from 2020 to
  2027.

3
Anticoagulant Reversal Drugs Market Overview
Email sales_at_theinsightpartners.com

• Anticoagulant reversal drugs are required to
  reverse the effect of anticoagulation in certain
  situations such as unplanned surgery, overdose of
  anticoagulant therapy, and uncontrolled bleeding.
  In medical conditions such as venous
  thromboembolism, atrial fibrillation (AF),
  mechanical valve replacement, and other
  coagulation disorders such as antiphospholipid
  antibody syndrome, Factor V Leiden, anticoagulant
  reversal drugs are used.
• Geographically, the anticoagulant reversal drugs
  market is segmented into North America, Europe,
  Asia Pacific, the Middle East and Africa, and
  South and Central America. North America held the
  largest market share in 2019. In North America,
  the US is the largest market for anticoagulant
  reversal drugs. The growth of the market in the
  region is attributed to the presence of key
  market players and their product development
  efforts. Additionally, the escalating prevalence
  of atrial fibrillation further contributes to the
  growth of the anticoagulant reversal drugs market
  in North America.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product (Prothrombin Complex Concentrates,
  Vitamin K, Protamine, Tranexamic Acid,
  Idarucizumab, and AndeXXa)
• Distribution channel (Hospital Pharmacies, Retail
  Pharmacies, and Others)

Download Sample Here
5
Anticoagulant Reversal Drugs Market Value
Email sales_at_theinsightpartners.com

• CAGR of 12.6
• (2020 - 2027)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Boehringer Ingelheim International GmbH
• Pfizer Inc
• Octapharma AG
• Amag Pharmaceuticals, Inc
• Fresenius Kabi AG
• Alexion Pharmaceuticals, Inc. (Portola
  Pharmaceuticals)
• CSL Limited
• China Biologic Products, Inc
• Grifols, S.A
• Shanghai RAAS Blood Products Co., Ltd.

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com